RECENT COMMENTS

Rajesh Kumar: Is it helpfull for Overian cancer patient at advance stage? Rajesh Kumar +919681303310   »Read more

Cindy: I'm not a medical professional. My mother has been diagnosed with CUP - and was treated several year [...]   »Read more

Rajesh Kumar: +919681303310.   »Read more

Rajesh Kumar: Please write your comment here   »Read more

christian: Is gabapentin has been proposed to treat peripheric neuropathy induced by chemotherapy. At low dosa [...]   »Read more

Media Events

Recent Media Event:

World Conference of Science Journalists
27th - 29th June 2011
Doha, Qatar

Slides from the session
ESO Putting Cancer on Global Agenda

As part of the World Conference of Science Journalists the European School of Oncology held a lunch time session on 27th June 2011 titled:

Putting Cancer on the Global Health Agenda

During the session journalists were encouraged to take action over the coming two months to raise awareness about the upcoming UN Summit on Non-communicable Diseases and to work with the cancer community to put cancer on the global health agenda.

Main Speaker:
Cary Adams, Union for International Cancer Control (UICC), Switzerland

Panelists:
Anna Wagstaff, Assistant Editor for Cancer World magazine, United Kingdom
Mohammed Yahia, Nature Middle East

Moderator:
Kathy Redmond, European School of Oncology (Cancer Media Service), Italy

Previous Media Events:

Cancer Time for a Reality Check
was held on Friday 26th October 2007 

You can view the Forum by clicking on the link below
http://esomediaforum.webcasting.it/ 

The following article on the Media Forum appeared in Cancer World magazine, issue 22. 

Our responsibility, our choices ESO invites the media to a reality check on cancer 
Anna Wagstaff 


Further information
As part of its 25th anniversary celebrations the European School of Oncology (ESO) organised a unique event on 26th October 2007, that gave journalists the opportunity to question leading researchers, clinicians, patient advocates and industry leaders about how they intend to meet the key challenges in cancer care today. 

Media Forum Programme 

The Forum included four sessions: 
Have we lost the plot in our quest to find cancer cures? 
Is rationing expensive cancer drugs the answer to spiralling health care spending? 
Are we rewarding mediocrity while penalising real innovation in cancer research? 
Can tumour gene profiling live up to expectations? 

Each session was moderated by internationally-renowned journalists including:
Jonathan Alter, Senior editor, Newsweek, US 
Sarah Boseley, Health editor, The Guardian, UK 
Istvan Palugyai, Editor, Nepszabadsag, HR and President of the European Union Science Journalists' Associations 
Paul Benkimoun, Health correspondent, Le Monde, FR
 
Invited experts briefly presented their perspective on the topic under discussion and then all the panellists took questions from the audience. Speakers included: 

Franco Cavalli, Co-chairman of ESO Scientific Committee 
Alexander Eggermont, Head of surgical oncology, Eramus University Medical Center - Daniel den Hoed Cancer Center, NL 
Lynn Faulds Wood, President, European Cancer Patient Coalition, UK 
Silvio Garattini, Pharmacologist, Mario Negri Pharmacology Research Institute, IT 
John Ioannidis, University of Ioannina, GR 
Harpal Kumar, Chief executive, Cancer Research UK 
Clifton Leaf, Journalist and cancer advocate, US
Scott Lippman, M.D, The University of Texas M.D Anderson Cancer Center, US
Larry Norton, Memorial Sloan-Kettering, US 
Bob Pinedo, Director, Vrije Universiteit medical centre, NL
Dinesh Purandare, Vice President and Head of Oncology Centre of Excellence, GlaxoSmithKline, UK
Mike Richarads, National Cancer Director for England, UK 
Umberto Veronesi, European Institute of Oncology, IT 
Brent Vose, Vice President and Head of Oncology, AstraZeneca, UK 

This event was open to journalists from a broad range of media including consumer, financial and scientific publications.

 
 

CancerWorld invites you to visit:

 
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck Serono, Novartis, Roche and Sanofi Aventis.